⌘K

Home/Filings/4/0001415889-25-015216

4//SEC Filing

Lyons-Williams Lori 4

Accession 0001415889-25-015216

CIK 0001673772other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:02 PM ET

Size

5.4 KB

Accession

0001415889-25-015216

Insider Transaction Report

Form 4

Period: 2025-05-29

RAPT Therapeutics, Inc.RAPT

Lyons-Williams Lori

Director

Transactions

Award
Director Stock Option (right to buy)
2025-05-29+257,832→ 257,832 total
Exercise: $0.93Exp: 2035-05-28→ Common Stock (257,832 underlying)

Footnotes (1)

[F1]The Option shall vest in 12 equal monthly installments from date of grant of May 29, 2025.

Documents

1 file

4
form4-06022025_090616.xmlPrimary

Issuer

RAPT Therapeutics, Inc.

CIK 0001673772

Entity typeother

Related Parties

1

filerCIK 0001693564

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 5:02 PM ET
Size: 5.4 KB

View on SEC.gov